IM Cannabis (US:IMCC) Prnewswireยท2025-08-04 11:00Company Overview - IM Cannabis Corp. (NASDAQ: IMCC) is a leading medical cannabis company operating in Israel and Germany, focusing on premium cannabis products for medical patients [2][3] - The company aims for sustainable and profitable growth in its key markets, leveraging a data-driven approach and a globally sourced product supply chain [2] Operational Highlights - The IMC ecosystem in Israel includes subsidiaries that import and distribute cannabis, operate medical cannabis retail pharmacies, and manage online platforms and distribution centers [3] - In Germany, IMC operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical patients [3] Upcoming Financial Reporting - IM Cannabis Corp. will report its operational and financial results for the second quarter of 2025 on August 12, 2025, before the market opens [1]